BHV-1300 reduced total IgG by up to 84% in a four-week Phase 1 study. The treatment was well-tolerated, with no serious adverse events reported. Get access to the leaderboards pointing to tomorrow’s ...

Add Yahoo as a preferred source to see more of our stories on Google. Galeries Lafayette said it is in exclusive talks to sell the historic BHV Marais department store to Groupe SGM (which stands for ...

On Monday, Biohaven Ltd. (NYSE:BHVN) revealed clinical and regulatory milestones across its proprietary Molecular Degrader of Extracellular Proteins (MoDE) platform and its glutamate modulation and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Biohaven has commenced a randomised Phase II/III trial of the tyrosine kinase 2 (TYK2) / Janus Kinase 1 (JAK1) inhibitor, BHV-8000, aimed at treating early Parkinson's disease (PD). The global, ...

Forbes contributors publish independent expert analyses and insights. Mark Faithfull is London-based and covers retail and real estate Paris, protests and packed aisles: Shein's arrival at the BHV ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a phase 2/3 trial. The registrational study assessed BHV-7000, a drug designed to selectively activate Kv7.2/Kv7.3, an ion ...

PARIS — French department store group Galeries Lafayette is ending its affiliation with BHV parent company Société des Grands Magasins, or SGM, following public backlash over SGM’s decision to open ...

Reported expanded safety results from BHV-7000 Phase 1 multiple ascending dose studies, including the once-daily extended-release formulation being evaluated in ongoing Phase 2 and 3 clinical studies, ...

PARIS — Galeries Lafayette announced Saturday it is in exclusive negotiations to sell the historic building housing the BHV department store. The French retail group said the potential buyer was “an ...

Biohaven has announced findings from its Phase II proof-of-concept trial of BHV-7000 in adults with major depressive disorder (MDD), focusing on the reduction of depressive symptoms as measured by the ...